SC Capital II Sponsor LLC - 28 Nov 2025 Form 4 Insider Report for SC II Acquisition Corp.

Reporting relationship: 10%+ Owner
Issuer ticker: SCII, SCIIR, SCIIU on Nasdaq
Reported as of: 28 Nov 2025
Net transaction value: +$2,550,000
SEC form: 4
Accepted by SEC: 01 Dec 2025, 17:20:47 UTC
Prior SEC filing: 25 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Menachem Shalom, as Authorized Signatory of SC Capital II Sponsor LLC

Key filing fact

SC Capital II Sponsor LLC filed Form 4 for SC II Acquisition Corp. on 01 Dec 2025.

Key facts

This page summarizes SC Capital II Sponsor LLC's Form 4 filing for SC II Acquisition Corp..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Dec 2025, 17:20.

Change

Previous filing in this sequence was filed on 25 Nov 2025.
Current net transaction value: +$2,550,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (4)

CIK 0002076738 Primary reporting owner

SC Capital II Sponsor LLC

Relationship: 10%+ Owner
Address: 575 FIFTH AVENUE, 14TH FLOOR, NEW YORK
Signature: /s/ Menachem Shalom, as Authorized Signatory of SC Capital II Sponsor LLC
Signature date: 01 Dec 2025

CIK 0002095058

Nukkleus Defense Technologies, Inc.

Relationship: 10%+ Owner
Address: 575 FIFTH AVENUE, 14TH FLOOR, NEW YORK
Signature: /s/ Menachem Shalom, as CEO of Nukkleus Defense Technologies, Inc., the managing member of the Sponsor
Signature date: 01 Dec 2025

CIK 0001787518

Nukkleus Inc.

Relationship: 10%+ Owner
Address: 575 FIFTH AVENUE, 14TH FLOOR, NEW YORK
Signature: /s/ Menachem Shalom, as CEO of Nukkleus, Inc.
Signature date: 01 Dec 2025

CIK 0002030245

Shalom Menachem

Relationship: CEO, Director
Address: 575 FIFTH AVENUE, 14TH FLOOR, NEW YORK
Signature: /s/ Menachem Shalom
Signature date: 01 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KCHV transaction

Class A ordinary shares

Purchase

Transaction value: $2,550,000
Shares: +255,000
Change %
Price: $10.00
Shares after: 255,000
Date: 28 Nov 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KCHV transaction Derivative

Right to receive one-fifth of one Class A ordinary share

Purchase

Transaction value
Shares: +255,000
Change %: +3.5%
Price
Shares after: 7,443,857
Date: 28 Nov 2025
Ownership: Direct
Underlying class: Class A Ordinary Shares
Underlying amount: 51,000
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects the 255,000Class A ordinary shares of SC II Acquisition Corp. (the "Issuer") that are included in the 255,000 private placement units of the Issuer purchased by SC Capital II Sponsor LLC ("Sponsor"). Each private placement unit was purchased for $10 per unit and consists of one Class A ordinary share and one right to receive one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination.

Footnote F2

The Sponsor is the record holder of the shares reported herein. The sole managing member of the Sponsor is Nukkleus Defense Technologies, Inc., a Nevada corporation (the "Managing Member"), which is a subsidiary of Nukkleus, Inc., a Delaware corporation ("Nukkleus"). Mr. Menachem Shalom is the CEO and a director of each of the Issuer, the Managing Member and Nukkleus. Mr. Shalom serves as the CEO and sole director of the Managing Member at the discretion of the Board of Directors of Nukkleus. Mr. Shalom, solely in his capacity as CEO and sole director of the Managing Member, has voting and dispositive control over the Class A ordinary shares and Class B ordinary shares held by the Sponsor and reported hereunder. Mr. Shalom disclaims beneficial ownership to these securities other than to the extent that he has a pecuniary interest therein.

Footnote F3

Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights.

Footnote F4

Represents (i) the 51,000 Class A ordinary shares referred to in footnotes 1 and 3 and (ii) 7,392,857 Class B ordinary shares held by the Sponsor acquired pursuant to a subscription agreement by and between the Issuer and the Sponsor.